Your browser doesn't support javascript.
loading
Delayed Improvement of Depression and Anxiety after Transcatheter Aortic Valve Implantation (TAVI) in Stages of Extended Extra-Valvular Cardiac Damage.
Bäz, Laura; Puscholt, Marisa; Lasch, Claudia; Diab, Mahmoud; Möbius-Winkler, Sven; Schulze, P Christian; Dannberg, Gudrun; Franz, Marcus.
Afiliação
  • Bäz L; Department of Internal Medicine I, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
  • Puscholt M; Department of Internal Medicine I, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
  • Lasch C; Department of Internal Medicine I, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
  • Diab M; Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
  • Möbius-Winkler S; Department of Internal Medicine I, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
  • Schulze PC; Department of Internal Medicine I, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
  • Dannberg G; Department of Internal Medicine I, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
  • Franz M; Department of Internal Medicine I, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
J Clin Med ; 10(8)2021 Apr 08.
Article em En | MEDLINE | ID: mdl-33918058
BACKGROUND: Depression and anxiety are frequently occurring and likely to be linked to the severity of cardiac diseases like aortic stenosis (AS). This seems to be of interest since a staging classification of extra-valvular cardiac damage in AS has been introduced and shown to be of prognostic relevance. OBJECTIVE: The current study aimed to investigate the frequency of depression and anxiety in association to staging and their dynamics after transcatheter aortic valve implantation (TAVI). METHODS: A total number of 224 AS patients undergoing TAVI were classified according to the 2017 staging classification into stage 0 to 4 and further dichotomized into group A (stage 0 to 2) and B (stage 3 and 4). Using the Hospital Anxiety and Depression Scale (HADS-D), patients were assigned to depressive versus non-depressive or anxious versus non-anxious per staging group respectively, and analyzed at baseline, 6 weeks, 6 months and 12 months after TAVI. RESULTS: After dichotomization, 158 patients (70.5%) were assigned to group A and 66 patients (29.5%) to group B. The part showing pathologic values for depression was 25.4% (57/224 patients) in the entire collective, 26.6% (42/158 patients) in group A and 22.7% (15/66 patients) in group B (p = n.s.). The proportion showing pathologic values for anxiety was 26.8% (60/224 patients) in the entire collective and did not differ between group A (24.7%, 39/158 patients) and B (31.8%, 21/66 patients) (p = n.s.). In patients revealing pathologic values for depression or anxiety prior to TAVI, there were significant and stable improvements over time observable already in short-term (6 weeks) follow-up in group A, and likewise, but later, in long-term (6/12 months) follow-up in group B. CONCLUSIONS: Although of proven prognostic relevance, higher stages of extra-valvular cardiac damage are not associated with higher rates of pre-existing depression or anxiety. The TAVI procedure resulted in a persisting reduction of depression and anxiety in patients showing pathologic values at baseline. Notably, these improvements are timely delayed in higher stages.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article